The trial to induction the human papillomavirus (HPV) testing into cervical cancer screening in Fukui prefecture, Japan

The trial to induction the human papillomavirus (HPV) testing into cervical cancer screening in Fukui prefecture, Japan - FCCS (Fukui Cervical Cancer Screening) study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025977

Enrollment

14000

Registered

2017-02-06

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine cervical cancer

Interventions

biopsy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Participants were recruited from among women aged 25 to 69 years, who participated in cervical cancer screening programs from eight cities in Fukui prefecture between May 2015 and March 2016.

Exclusion criteria

Exclusion criteria: absent uterus, treatment or follow-up of CIN, pregnant women

Design outcomes

Primary

Measure	Time frame
The sensitivities for cervical intraepithelial neoplasia (CIN) 2 or worse on cytology, HPV testing, and cotesting with cytology and HPV testing	—

Secondary

Measure	Time frame
The prevalence of high-risk HPV, HPV16 genotype and HPV18 genotype by age group	—

Countries

Japan

Contacts

Public ContactTetsuji Kurokawa

University of Fukui Department of Obstetrics and Gynecology

kurotetu@u-fukui.ac.jp0776618392

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026